{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:48:09Z","timestamp":1780436889467,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.transproceed.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:16:54Z","timestamp":1745997414000},"page":"713-722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and Safety of Induction Therapy in Kidney Transplant Recipients: A Propensity Score Matching Analysis in a Multicenter Retrospective Observational Study"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1313-8856","authenticated-orcid":false,"given":"Vural Taner","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Ko\u00e7ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Sinangil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmi","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eebnem","family":"Karakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezzan Eren","family":"Sadio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Yelken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murathan","family":"Uyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Velio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erg\u00fcn","family":"Parmaks\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Ar\u0131","family":"Bak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dclkem","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhan","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad","family":"Dheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayd\u0131n","family":"T\u00fcrkmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.transproceed.2025.04.003_bib0001","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.1203261","article-title":"In kidney transplant patients, alemtuzumab but not basiliximab\/low-dose rabbit anti-thymocyte glob\u00fclin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development","volume":"191","author":"Todeschini","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.transproceed.2025.04.003_bib0002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.transproceed.2011.11.026","article-title":"Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report","volume":"44","author":"Zhao","year":"2012","journal-title":"Transpl Proc"},{"issue":"8","key":"10.1016\/j.transproceed.2025.04.003_bib0003","first-page":"1587","article-title":"The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients","volume":"29","author":"Bouvy","year":"2014","journal-title":"Nephrol Dial Transpl Publ Eur Dial Transpl Assoc Eur Ren Assoc"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0004","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/TP.0b013e3181fecfcb","article-title":"Induction immunosuppression improves long-termgraft and patient outcome in organ transplantation: An analysis of united network for organ sharing registrydata","volume":"90","author":"Cai","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/tri.12043","article-title":"Selection of induction therapy in kidney transplantation","volume":"26","author":"Hardinger","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0006","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/ndt\/gfw086","article-title":"Efficacy and safety of antibody induction therapy in the current era of kidney transplantation","volume":"31","author":"Opelz","year":"2016","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0007","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2165\/11631300-000000000-00000","article-title":"Induction therapy in renal transplant recipients: how convincing is the current evidence?","volume":"72","author":"Wagner","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0008","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10157-017-1480-z","article-title":"Induction therapy of basiliximab versus antithymocyte glob\u00fclin in renal allograft: a systematic review and meta-analysis","volume":"22","author":"Wang","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0009","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.transproceed.2011.12.055","article-title":"Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes","volume":"44","author":"Foster","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.transproceed.2016.02.019","article-title":"Induction immunosuppressive therapy use in deceased donor kidney transplantation: 11-year experience in veracruz, Mexico","volume":"48","author":"Martinez-Mier","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0011","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.13884","article-title":"Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?","volume":"17","author":"Hellemans","year":"2017","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.transproceed.2025.04.003_bib0012","first-page":"1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transpl"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0013","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cellmediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transpl"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0014","series-title":"R: A language and environment for statistical computing","year":"2023"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0015","series-title":"RStudio: Integrated Development for R","year":"2023"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0016","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1432-2277.2009.01004.x","article-title":"Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients","volume":"23","author":"Fleming","year":"2010","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.transproceed.2025.04.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2215536","article-title":"Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk \u2013 a retrospective analysis of UNOS database","volume":"55","author":"Ali","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0018","first-page":"820","article-title":"Increased risk of rejection after basiliximab induction in sensitized kidney transplant recipients without pre-existing donor-specific antibodies \u2013 a retrospective study","volume":"32","author":"Goumard","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0019","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.transproceed.2017.02.006","article-title":"Use of ATLG-fresenius as an induction agent in deceased-donor kidney transplantation","volume":"49","author":"Yilmaz","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2025.04.003_bib0020","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.transproceed.2010.02.088","article-title":"Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis","volume":"42","author":"Liu","year":"2010","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525002039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525002039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:36:40Z","timestamp":1778243800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134525002039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0041134525002039"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.04.003","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Induction Therapy in Kidney Transplant Recipients: A Propensity Score Matching Analysis in a Multicenter Retrospective Observational Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}